The idea that cancer is a metabolic disease comes from all of the following except

The idea that cancer is a metabolic disease comes from all of the following except: 1. Glycolysis is preferentially used by cancer cells 2. Certain CAC cycle intermediates are involved in the regulation of HIF-1, a transcriptional regulator 3. HIF-1 is hydroxylated by prolyl hydroxylase in normal oxygen conditions 4. Mutations in pyruvate dehydrogenase kinase inhibits glycolysis

The correct answer and explanation is:

The correct answer is 4. Mutations in pyruvate dehydrogenase kinase inhibits glycolysis.

Explanation:
The concept that cancer is a metabolic disease stems from observations of altered cellular metabolism in cancer cells. Cancer cells often show a preference for glycolysis over oxidative phosphorylation, even in the presence of oxygen. This phenomenon, known as the Warburg effect, is a hallmark of many cancer types. Here’s a breakdown of the provided options:

1. Glycolysis is preferentially used by cancer cells: This is a well-established feature of cancer metabolism. Cancer cells often undergo glycolysis at a much higher rate than normal cells, even in the presence of oxygen. This preference for glycolysis allows cancer cells to generate ATP and biosynthetic intermediates more rapidly, supporting rapid cell growth and proliferation.
2. Certain CAC cycle intermediates are involved in the regulation of HIF-1, a transcriptional regulator: This is also correct. Intermediates from the citric acid cycle (CAC) play a role in regulating hypoxia-inducible factor 1 (HIF-1). In low-oxygen conditions (hypoxia), HIF-1 activates genes involved in glycolysis and angiogenesis, which are crucial for cancer cells’ survival in the tumor microenvironment.
3. HIF-1 is hydroxylated by prolyl hydroxylase in normal oxygen conditions: This statement is accurate. In normal oxygen conditions, HIF-1 is hydroxylated by prolyl hydroxylase, which marks it for degradation. In hypoxic conditions, this hydroxylation does not occur, allowing HIF-1 to accumulate and activate genes that promote glycolysis and angiogenesis.
4. Mutations in pyruvate dehydrogenase kinase inhibits glycolysis: This is incorrect. Pyruvate dehydrogenase kinase (PDK) inhibits the conversion of pyruvate to acetyl-CoA by phosphorylating and inactivating pyruvate dehydrogenase (PDH). This inhibition reduces oxidative phosphorylation and promotes glycolysis. Therefore, mutations in PDK would actually increase glycolysis rather than inhibit it. This makes this statement the exception.

In summary, cancer cells utilize altered metabolic pathways to support rapid growth and survival, and the statements about glycolysis, HIF-1 regulation, and CAC intermediates are all consistent with this idea. However, mutations in pyruvate dehydrogenase kinase would not inhibit glycolysis, making option 4 the correct answer.